Leadless Pacemaker Pacing Timing via Extracardiac P-Wave Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The absence of an intracardiac lead in leadless cardiac pacemakers (LCPs) makes it difficult to detect atrial events for cardiac resynchronization therapy (CRT), as P-waves can be challenging to detect or highly variable when sensed by extracardiac devices like subcutaneous cardiac monitors or implantable defibrillators.
Innovation Solution
An LCP is configured to provide pacing therapy using a Pace to Pace interval, with a second device analyzing cardiac signals to determine the P-wave to Pace interval and adjusting this interval to achieve beneficial CRT therapy, either by monitoring cardiac activity, identifying P-waves relative to pacing pulses, or using predetermined ranges and communication to modify the pacing timing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If transvenous leads are used for CRT, then atrial event detection is reliable, but device complexity and patient morbidity increase
Solution Approach 1:
The patent extracts the leadless pacemaker from the traditional transvenous lead system, placing the pacing device entirely within the heart chamber without requiring venous access. This eliminates the transvenous leads and associated morbidity while maintaining pacing functionality through alternative sensing methods that do not rely on lead-based atrial event detection
Solution Approach 2:
The patent introduces an intermediary computing device that receives data from the leadless pacemaker and performs sophisticated analysis to determine optimal pacing timing. This intermediary acts as a mediator that compensates for the lack of direct atrial event detection by analyzing various physiological parameters and calculating appropriate pace-to-pace intervals for CRT
2Ease of operation
If extracardiac devices sense P-waves for CRT timing, then leadless pacing is achieved, but P-wave detection precision deteriorates
Solution Approach 1:
The patent makes the extracardiac sensing device multi-functional by using it not only for P-wave detection but also for QRS complex analysis, T-wave monitoring, and overall cardiac rhythm assessment. This multi-functionality allows the device to compensate for reduced P-wave detection precision by utilizing multiple physiological signals to determine optimal pacing timing
Solution Approach 2:
The patent implements feedback mechanisms where the extracardiac device continuously monitors cardiac signals including P-waves, QRS complexes, and T-waves, then uses this feedback to dynamically adjust and refine the determination of pace-to-pace intervals. The system learns from ongoing signal analysis to improve timing precision despite the limitations of extracardiac P-wave sensing
3Ease of operation
If Pace to Pace interval is fixed, then device operation is simple, but CRT effectiveness decreases
Solution Approach 1:
The patent transitions from fixed pacing intervals to dynamic, adaptive pacing by using computational analysis of real-time cardiac signals. The system continuously adjusts the pace-to-pace interval based on detected P-wave timing, QRS morphology, and other physiological parameters, allowing the pacing strategy to adapt to changing cardiac conditions while maintaining CRT effectiveness
Solution Approach 2:
The patent changes the pacing parameter from a fixed interval to a variable interval determined by multiple physiological parameters including P-wave to R-wave interval, QRS duration, and T-wave timing. This parameter-based approach allows sophisticated CRT optimization while the intermediary computing device handles the complexity of multi-parameter analysis and adjustment
Data Source
AI summary
Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker (LCP) and an extracardiac device (ED). The LCP is configured to deliver pacing therapy at a pacing interval. Illustratively, the ED may be configured to analyze the cardiac cycle including a portion preceding the pacing therapy delivery for one or several cardiac cycles, and determine whether an interval from the P-wave to the pace therapy in the cardiac cycle(s) is in a desired range. In an example, if the P-wave to pace interval is outside the desired range, the ED communicates to the LCP to adjust the pacing interval.